ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Phreesia Life Sciences Named One of MM+M’s “Best Places to Work 2022”

Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that for the second year in a row, the healthcare marketing industry trade publication Medical Marketing and Media (MM+M) has named Phreesia Life Sciences to its list of Best Places to Work 2022.

Now in its fifth year, the annual review spotlights the healthcare marketing industry’s top agencies and service providers that support the life sciences industry as rated by employees themselves. Phreesia was one of only three companies recognized in the “Healthcare Service Providers” category, and one of just 12 companies or agencies featured overall.

MM+M spotlighted Phreesia’s inclusive culture, benefits and professional growth opportunities as standout features that make it a top-tier employer among healthcare service providers.

“We couldn’t be more honored to receive this recognition from our employees for the second consecutive year,” said Amy VanDuyn, Phreesia’s Senior Vice President, Human Resources. “Phreesia Life Sciences is focused on hiring and retaining passionate, curious and innovative employees who are ready to support our goal of improving patient health outcomes, and we’re thrilled to be named among the industry’s best destinations for talented individuals.”

Staffers gave Phreesia high marks for dedication to employees’ well-being and professional growth, as well as its efforts to ensure employees are connected with one another. MM+M highlighted the company’s use of cross-functional projects and several new initiatives it added this year, including an employee recognition plan that awards points that can be redeemed for gifts once benchmarks are achieved and a new hire mentorship and training program.

"I’m incredibly proud of the way Phreesia Life Sciences continues to meet post-COVID crisis changes across the industry. We've accomplished this through both our support of crucial and timely research and outreach efforts around important healthcare topics like vaccination, and also our continued investments in cultivating a spirit of collaboration and inclusivity while working remotely,” said David Linetsky, Phreesia’s Senior Vice President, Life Sciences.

About Phreesia Life Sciences

Phreesia empowers life sciences companies to connect meaningfully with clinically relevant patients, delivering tailored health content in a one-to-one setting. Our PatientConnect offering identifies and motivates the right patients to initiate meaningful brand conversations, while our PatientInsights product enables our clients to better understand key patient populations.

Phreesia meets patients where they are, both virtually and in person, and reaches them at multiple touchpoints throughout their healthcare journey.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.